Hemotek

Executive OfficesTexas, United States11-50 Employees

Hemotek is a Frisco, Texas-based company focused on the research, development, and commercialization of oxygenated therapeutics. Its lead asset, Ox66, is a soluble oxygen powder described as the only non-gaseous form of oxygen available as a powder, developed to support prevention and treatment across living systems through a novel delivery approach. After more than a decade of testing in diverse markets, Ox66 is sold to several commercial customers while the company advances toward FDA approval for medical use. The organization operates in a biotech-oriented space and has pursued collaborations with external partners, including a licensing agreement with Baylor University dating back to 2013. With a relatively small to mid-sized team, Hemotek emphasizes advancing oxygen-based therapies and expanding its clinical and commercial applications.

Sign up for free to view info

Email Format Employee directory